Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

There's more to see -- the rest of this topic is available only to subscribers.